These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

540 related items for PubMed ID: 11993366

  • 1. A critical tipping point.
    Zuckerman MB.
    US News World Rep; 2002 Apr 22; 132(13):72. PubMed ID: 11993366
    [No Abstract] [Full Text] [Related]

  • 2. The FDA's drug review process: ensuring drugs are safe and effective.
    Meadows M.
    FDA Consum; 2002 Apr 22; 36(4):19-24. PubMed ID: 12184298
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. FDA and EMEA pool scientific advice.
    Katsnelson A.
    Nat Biotechnol; 2004 Dec 22; 22(12):1490-1. PubMed ID: 15583642
    [No Abstract] [Full Text] [Related]

  • 7. Balancing US patent and FDA approval processes: strategically optimizing market exclusivity.
    Fernandez DS, Huie JT.
    Drug Discov Today; 2004 Jun 15; 9(12):509-12. PubMed ID: 15183155
    [No Abstract] [Full Text] [Related]

  • 8. The big gap at the FDA.
    Stipp D.
    Fortune; 2002 Jul 22; 146(2):113-4, 116. PubMed ID: 12141178
    [No Abstract] [Full Text] [Related]

  • 9. What ails the FDA?
    Okie S.
    N Engl J Med; 2005 Mar 17; 352(11):1063-6. PubMed ID: 15784660
    [No Abstract] [Full Text] [Related]

  • 10. Drugs with breakthrough status charm investors.
    Senior M.
    Nat Biotechnol; 2013 Nov 17; 31(11):945-7. PubMed ID: 24213748
    [No Abstract] [Full Text] [Related]

  • 11. The Prescription Drug User Fee Act of 1992: speeding up the drug approval process.
    Bierut MB.
    Healthspan; 1992 Dec 17; 9(11):12-4. PubMed ID: 10123552
    [No Abstract] [Full Text] [Related]

  • 12. BIO and biogenerics.
    Feldbaum CB.
    Nat Biotechnol; 2005 Jan 17; 23(1):17; discussion 17. PubMed ID: 15637607
    [No Abstract] [Full Text] [Related]

  • 13. Trials and error.
    Jacobs T.
    Nat Biotechnol; 2005 Dec 17; 23(12):1481. PubMed ID: 16333284
    [No Abstract] [Full Text] [Related]

  • 14. The special treatment.
    Osborne R.
    Nat Biotechnol; 2008 May 17; 26(5):487-9. PubMed ID: 18464770
    [No Abstract] [Full Text] [Related]

  • 15. Steve Carney talks to Vincent Lee on the pharma industry, the FDA and public education with respect to drugs and their development.
    Lee VH.
    Drug Discov Today; 2005 Nov 01; 10(21):1411-4. PubMed ID: 16243258
    [No Abstract] [Full Text] [Related]

  • 16. The drive to reform the FDA gains momentum.
    Gatty B.
    Hosp Formul; 1995 Mar 01; 30(3):178, 177. PubMed ID: 10141250
    [No Abstract] [Full Text] [Related]

  • 17. Maine law requires drug companies to provide clinical trial data.
    Appell D.
    J Natl Cancer Inst; 2005 Sep 07; 97(17):1246. PubMed ID: 16145043
    [No Abstract] [Full Text] [Related]

  • 18. The Prescription Drug User Fee Act: is a faster Food and Drug Administration always a better Food and Drug Administration?
    Zelenay JL.
    Food Drug Law J; 2005 Sep 07; 60(2):261-338. PubMed ID: 16094773
    [No Abstract] [Full Text] [Related]

  • 19. Drive for drugs leads to baby clinical trials.
    Nature; 2006 Mar 23; 440(7083):406-7. PubMed ID: 16554774
    [No Abstract] [Full Text] [Related]

  • 20. Who would approve new drugs if there were no FDA?
    Gatty B.
    Hosp Formul; 1995 Jan 23; 30(1):58, 57. PubMed ID: 10139726
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.